Clinical Trial Update: Study of Escalating Doses of NRL001 Given in Slow-release Rectal Suppositories of Different Weights [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating escalating doses of NRL001 delivered as slow-release rectal suppositories for incontinence; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Incontinence

Drugs mentioned

• NRL001

Snippet

Sponsor: Norgine | Conditions: Incontinence | Phase 1 | Status: COMPLETED